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ABSTRACT 
Background and Objectives: To find antagonistic bacteria with potential antifungal activity against some pathogenic fungi, 
including Aspergillus niger, A. flavus, Fusarium moniliforme and Penicillium marneffei, a total of 148 agricultural soil 
samples from different sites of Tehran were examined. 
Materials and Methods: Antagonistic soils were selected by screening against A. niger on glucose-yeast extract (GY) agar 
using a visual agar plate assay method. All growing bacteria were examined for antifungal activity, and antagonistic bacteria 
identified based on 16S rRNA sequence analysis. Among a total number of 97 bacteria isolated form inhibitory soils (36 
samples), 16 bacteria were reported as strong growth inhibitors in co-cultures on GY agar with all tested fungi at variable 
degrees. Fungal growth inhibitory bacteria were cultured against all fungi and growth inhibition was measured and analyzed 
between test and control groups by statistical analysis (ANOVA). 
Results: Molecular identification of antagonistic bacteria indicated that most bacterial isolates belonged to the genus Bacillus 
(81.25%), including B. subtilis (5 isolates), B. amyloliquefaciens (6 isolates) and B. valismortis (2 isolates), followed by one 
isolate (6.25%) from each Streptomyces sp., Pseudomonas chlororaphis and Acinetobacter baumannii. Based on the visual 
plate assay results, total fungal growth inhibition of all bacteria was reported in the range of 13.2 to 68.3%. P. chlororaphis 
S105 was reported as the most potent antagonistic bacterium which inhibited the growth of A. niger by 68.3%, followed by 
F. moniliforme (66.4%), A. flavus (64.7%) and P. marneffei (57.1%). 
Conclusion: P. chlororaphis and some other inhibitory bacteria reported in the present study, they may be considered not 
only as a rich source of useful metabolites with potential application in antifungal drug discovery, but also as potential 
candidates for biological control programs. 
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INTRODUCTION  
                
The fungal kingdom comprises an estimated 1.5 
million species on our planet. Among nearly 100,000 
described species of fungi, approximately 400 species 
is now recognized as pathogens to humans, animals 
and  plants.  They  include  both  molds  and  yeasts 
from different genera and species with the majority 
belonging to the genera Aspergillus, Penicillium and 
Fusarium (1, 2).   
The  fungi  belonging  to  the  genera  Aspergillus, 
Penicillium  and  Fusarium  are  important  from  the 
point of not only causing life-threatening infections 
in  humans  and  animals,  but  also  producing  toxic 
metabolites  named  “mycotoxins”  (3).  Among 
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Aspergillus species, A. flavus is a human pathogen, 
allergen and mycotoxin producer, while A. niger is 
generally  involved  in  the  etiology  of  otomycosis 
aside  its  major  role  as  a  plant  pathogenic  fungus 
(3).  Fusarium  moniliforme  is  an  important  plant 
pathogenic  fungus  capable  of  producing  different 
mycotoxins  in  food  and  agricultural  commodities 
(1-3). Penicillium marneffei is a saprophytic fungus 
responsible for opportunistic invasive infections in 
immunocompromised patients (2).   
Synthetic  chemicals  including  antifungal  drugs 
and fungicides are widely used to control detrimental 
effects  of  fungi  on  human  health  and  agriculture. 
Although fungicides are a key component of disease 
management  programs,  they  suffer  from  large 
limitations including adverse reactions on biological 
systems,  development  of  resistance  by  fungal 
pathogens  and  undesirable  effects  on  non-target 
beneficial  microorganisms  sharing  the  ecosystem. 
Thus, there is a clear tendency towards optimization 
of environmentally-friendly fungicides that produce 
minimal damage to human health and surrounding 
ecosystem (4, 5). 
The primary current means for the identification of 
new antifungal agents are represented by screening of 
the vast biodiversity prevalent in natural resources such 
as  soil  samples,  marine  waters, insects,  and  tropical 
plants (6, 7). The need for safe and effective antifungal 
agents has triggered considerable interest in the isolation 
of new compounds from biological resources. Likewise, 
the rapid  emergence  of  fungal  pathogens  resistant  to 
currently available antibiotics has further compounded 
the dearth of novel antifungal agents.
Among  the  existing  biodiversity,  bacteria  have 
received  major  consideration  not  only  for  their 
extremely wide distribution and population diversity, 
but also for their capability to produce a wide array of 
bioactive metabolites with antimicrobial properties. 
Nowadays, hundreds of chemically diverse antifungal 
compounds have been isolated from a vast array of 
bacteria and there are more compounds waiting to 
be  discovered  by  researchers  yet  (8,  9).  Since  the 
production  of  antifungal  metabolites  in  bacteria  is 
quite dependent on the strain and species, ongoing 
search  for  finding  new  bacterial  populations  to 
increase the chance of discovering novel antifungals 
is currently done all over the world.   
In  the  present  study,  antifungal  activities  of  the 
soil  bacteria  identified  by  the  molecular  methods 
were  evaluated  against  some  important  pathogenic 
fungi in order to be considered not only as a potential 
candidate for biological control programs, but also 
for finding rich sources of useful metabolites with 
potential application in antifungal drug discovery. 
MATeRIAlS AND MeThODS
fungal strains and preparation of inoculums. 
A. niger, A. flavus, Fusarium moniliforme and Penici-
llium  marneffei  were  studied.  All  cultures  were 
obtained from the Department of Mycology, Pasteur 
Institute of Iran. For preparing fungal spores, fungal 
species were cultured on Sabouraud Dextrose Agar 
(Peptone  1.0%,  Glucose  2.0%,  Agar-agar  1.5%; 
E.  Merck,  Germany)  at  28ºC  for  10 days.  Spore 
suspensions  were  prepared  by  gently  rubbing  the 
culture  surface  by  glass  rod  after  adding  adequate 
amount of sterile distilled water contained 0.1% Tween 
80.  The  number  of  fungal  spores  was  determined 
microscopically with a hemacytometer (10).
Soil samples and initial screening for antagonistic 
bacteria. A total number of 148 soil samples were 
obtained  from  different  parts  of  the  province  of 
Tehran, Iran. All the samples were transferred to the 
laboratory  in  sterile  plastic  containers.  For  initial 
screening of inhibitory soils, 0.1 g of each soil sample 
was suspended in 0.5 ml 0.9% (w/v) NaCl, mixed by 
vortex for 30 s, and centrifuged at 2500 rpm for 30 
s. Two μl of A. niger conidial suspension (2 × 105 
conidia/ml)  was  spotted  onto  the  center  of  a  GY 
(Glucose 2.0%, Yeast extract 0.5%, Agar 1.5%)  plate, 
and 10 μl supernatant of each soil sample was placed 
around the periphery of the plate, 3 cm distance from 
the A. niger spot. Screen plates were incubated at 
28°C for 5 days and assessed visually for antifungal 
phenotypes (10). 
Isolation  and  screening  the  bacteria  for 
antifungal  activity.  Soil  samples  with  inhibitory 
activity  toward  the  growth  of  A.  niger  in  initial 
screening were streaked onto GY agar and incubated 
at 28°C until bacterial colonies developed. Individual 
colonies  were  inoculated  onto  GY  agar  and  they 
were  screened  for  antifungal  activity  as  described 
above. Pure cultures of bacterial isolates that showed 
antagonistic effects on A. niger were further tested 
for antifungal activity against selected fungi by visual 
agar plate assay according to Hua et al. with some 
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spore suspension (200 cells/µl) from each fungus was 
inoculated on GY agar plates in a single streak down 
the middle of plate. A single streak of each selected 
bacterium with antifungal activity grown overnight 
in Tryptic Soy Agar (TSA; Difco, Becton Dickinson, 
Franklin Lakes, NJ) at 28°C was suspended in 2.0 ml 
sterile  distilled  water  to  obtain  a  density  equal  to 
0.5× McFarland. Ten µl of each bacterial suspension 
was inoculated in peripheral lines in distance of 1.5 
cm from central line by tooth pick. Triplicate plates 
were incubated at 28°C for 7 days in static condition. 
Antifungal activity was assessed by comparing the zone 
of fungal growth inhibition in fungi co-cultured with 
bacteria as tests, in comparison with control plates which 
were inoculated only with corresponding fungi.
Identification of bacterial isolates. Antagonistic 
bacteria were identified by using 16S ribosomal RNA 
(rRNA) gene sequence analysis. Overnight cultures 
on LB medium at 30ºC were streaked on TSA plates. 
Single colonies from cultures grown on TSA at 28ºC 
were  suspended  in  2.0 ml  sterile  distilled  water  to 
obtain a density equal to 0.5× McFarland. Bacterial 
cells were pelleted by centrifugation at 12,000 × g 
for 10 min. and resuspended in 0.1 ml sterile distilled 
water.  Total  DNA  was  obtained  using  a  DNeasy 
Plant Mini kit (Qiagen) by following the supplier’s 
instructions.  16S  rRNA  gene  fragments  were 
amplified by polymerase chain reaction (PCR) using 
1 μl of each cell suspension as template and universal 
primers 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) 
and 1525R (5′AAGGAGGTGWTCCARCC-3′) (11). 
The PCRs were carried out using approximately 500 
ng of total bacterial DNA, 10 µl of 10x PCR buffer, 
8 µl of MgCl2 (25 mM), 10 µl of deoxynucleoside 
triphosphates (dNTPs) (2 mM each), 3.3 µl of each 
primer (20 µM), 0.5 µl of Taq polymerase (5 U/µl), 
and enough Milli Q water so that the final volume 
of the mixture was 100 µl. The PCR mixtures were 
denatured at  95°C  for  5  min,  which  was  followed 
by 35 cycles of 94°C for 30 s, 58°C for 30 s, and 
72°C  for  70  s  and  then a  final  extension  at  72°C 
for 5 min. Amplification was checked for purity by 
electrophoresis on a 1.0% agarose gel. The bands of 
interest were excised from the gel, and the DNA was 
purified using  QIAquick  PCR  purification  columns 
(Qiagen, Inc., Valencia, CA). Purified DNA fragments 
were  sequenced  using  the  same  sets  of  primers 
that were used  for  amplification by  an ABI  Prism 
BigDye®  Terminator  v3.1  Cycle  Sequencing  Kit 
(Applied Biosystems). Bacteria were identified based 
on sequence similarities to homologous 16S rRNA 
gene fragments in the Ribosomal Database Project 
database  (12)  (accessed  at  http://rdp.cme.msu.edu/
index.jsp).  For  biochemical  identification,  bacteria 
were first determined to be either Gram-positive or 
Gram-negative  using  potassium  hydroxide ( 13). 
Gram-positive  isolates  were  identified  using  GP2 
MicroPlates (Biolog), whereas Gram-negative isolates 
were  identified  using  GN2  MicroPlates ( Biolog), 
according  to  the  instructions  of  the  manufacturer. 
Identification was based on the similarity index of 
carbon source utilization by each isolate relative to 
that of identified reference strains in the Biolog GP 
and GN databases. 
Statistical Analysis.  Quantitative  data  of  fungal 
growth  were  analyzed  by  under  windows  SPSS 
version 16 program. The P < 0.05 was considered 
significant.
ReSUlTS
Initial screening of inhibitory soils and bacteria. 
Among  148  soil  samples  screened  for  antifungal 
activity against A. niger, 36 soils were found to be 
inhibitory for the fungus in GY plates. Fig. 1A shows 
fig. 1. Screening of soil samples and isolated bacteria for 
antagonistic activity against A. niger on GY agar. Fig. 1A 
shows inhibitory (a & d) and non-inhibitory (b & c) soils, 
while Fig 1B shows bacterial isolates inhibitory (e & h) and 
non-inhibitory (f & g) for fungal growth. 143 ANTAGONISTIC BACTeRIA fROM TehRAN SOIlS
inhibitory  (a  and  d)  and  non-inhibitory  (b  and  c) 
soils in initial screening against A. niger. Bacterial 
antagonism is visible as a clear zone of fungal growth 
inhibition around the isolates “a” and “d” from soil 
no. 75. A total number of 97 bacteria were isolated 
from inhibitory soils were classified according their 
degree of antagonism into three groups including i) 
strong (16 isolates), ii) moderate (32 isolates) and iii) 
no effect (49 isolates) based on visual agar plate assay 
on GY agar. Fungal growth inhibition by individual 
pure bacteria is shown in Fig. 1B as a clear zone of 
fungal growth retardation surrounding the bacterial 
colonies e and h in comparison with non-inhibitory 
bacteria i.e. isolates f and g. 
Identification of antagonistic bacteria. Identifica-
tion  of  antagonistic  bacteria  (group  i)  selected  by 
visual agar plate assay on GY agar was carried out 
by 16S ribosomal RNA (rRNA ~1 kb) sequencing 
using ABI prism big Dye terminator cycle sequencing 
apparatus.  PCR  was  carried  out  by  using  primers 
27F and 1525R and FASTA search of the GenBank 
database was used for identification of the isolates at 
species level. General characteristics of the identified 
fig. 2. Comparative results of the quantitative assay of the antifungal activity of identified soil bacteria in agar plate assay on 
GY agar. Results are from the means ± SEM of two separate experiments in triplicate sets for total bacteria in each species.
Antagonistic phenotypea Gram staining Isolate Species  Genus
zi – S1 A. baumannii Acinetobacter
zi/ci + S2 B. subtilis
Bacillus
zi/ci + S23 B. subtilis
zi + S105 B. subtilis
zi/ci + S115 B. subtilis
zi/ci + S140 B. subtilis
zi/ci + S23 B. amyloliquefaciens
zi/ci + S85 B. amyloliquefaciens
zi/ci + S102 B. amyloliquefaciens
zi/ci + S123 B. amyloliquefaciens
zi/ci + S124 B. amyloliquefaciens
zi/ci + S143 B. amyloliquefaciens
zi/ci + S24 B. valismortis
zi/ci + S121 B. valismortis
zi – S105 P. chlororaphis Pseudomonas
zi/ci + S40 Unknown Streptomyces
Table 1. General features of soil bacteria with strong inhibitory activity toward the growth of tested fungi. 
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bacteria are summarized in Table 1. They included 
Bacillus amyloliquefaciens (6 isolates), B. subtilis (5 
isolates), B. valismortis (2 isolates) and one isolate of 
each  Acinetobacter  baumannii,  Streptomyces  sp.  and 
Pseudomonas chlororaphis. Regard to the antagonistic 
phenotypes of isolated bacteria, it was shown that all 
the bacteria had both zone of growth inhibition (zi) and 
contact growth inhibition (ci) for fungi tested except 
A. baumannii S1, B. subtilis S105 and P. chlororaphis 
S105 which showed only zi for fungal growth. 
Antifungal activity against tested fungi. All 16 
identified bacteria were tested for potential antifungal 
activities  against  some  selected  fungi  visually  by 
comparing fungal growth in fungi co-cultured with 
bacteria relative to controls inoculated only with fungi. 
Antagonistic activity of selected bacteria against all 
tested fungi which was presented as mean zone of 
fungal  growth  inhibition  (Table  2). The  growth  of 
all tested fungi was inhibited by all selected bacteria 
by  different  extents  and  inhibition  was  significant 
for the majority of fungi in comparison with relative 
controls  (ANOVA,  P  <  0.05).  Comparative  results 
of  the  quantitative  assay  of  the  inhibitory  activity 
of  identified  soil  bacteria  against  selected  fungi 
are  shown  as  mean  of  growth  inhibition  for  each 
bacterial species in Fig. 2. Antifungal activities of 
A.  baumannii,  B.  subtilis,  B.  amyloliquefaciens, 
B. valismortis, P. chlororaphis, and Streptomyces 
sp.  isolates  against  tested  fungi  were  reported 
in  the  range  of  14.1-43.9%,  13.2-62.7%,  24.6-
66.0%, 25.7-60.0%, 57.1-68.3% and 20.7-33.0%, 
respectively.  P.  chlororaphis  S105  was  reported 
as the most potent antagonistic bacterium which 
inhibited the growth of A. niger by 68.3%, followed 
by F. moniliforme (66.4%), A. flavus (64.7%) and 
P. marneffei (57.1%). 
DISCUSSION
It has been reported that, on average, two or three 
antibiotics  derived  from  bacteria  enter  the  market 
Genera Species % of fungal growth inhibition for: 
A. niger                 A. flavus               F. moniliforme          P. marneffei 
Acinetobacter
A. baumannii S1 43.9* 16.8 14.1 33.6*
Bacillus
B. subtilis S2  52.8* 31.3* 44.5* 35.7*
B. subtilis  S23 35.3* 49.0* 25.8* 26.4*
B. subtilis S105 62.7* 39.0* 49.2* 26.3*
B. subtilis S115 13.2 35.7* 18.0 28.5*
B. subtilis S140 49.5* 32.5* 24.6* 33.6*
B. amyloliquefaciens  S23  33.0* 35.9* 24.6 28.6*
B. amyloliquefaciens S85 42.9* 34.8* 40.4* 40.7*
B. amyloliquefaciens S102 48.5* 32.3* 44.1* 45.7*
B. amyloliquefaciens S123 66.0* 60.1* 55.8* 45.5*
B. amyloliquefaciens S124  65.0* 62.3* 49.2* 42.8*
B. amyloliquefaciens S143 30.7* 32.4* 28.5* 45.6*
B. vallismortis S24 51.8* 44.7* 39.1* 40.7*
B. vallismortis S121 45.2* 60.0* 25.8 42.9*
Pseudomonas
P. chlororaphis S105 68.3* 64.7* 66.4* 57.1*
Streptomyces
Streptomyces  sp S40 33.0* 26.7* 20.7* 21.4*
Table 2. Inhibitory effects of antagonistic bacteria against some opportunistic fungi on GY agar.
aThe data are the mean ± SEM of two separate experiments in triplicate sets.
bAsterisks show statistically significant difference with a control (P < 0.05).
cControl cultures (non-exposed to the bacteria) for A. niger, A. flavus, F. moniliforme and  P. marneffei had mean growth rates 
of 30.3, 30.0, 25.6 and 14.0 mm, respectively.145 ANTAGONISTIC BACTeRIA fROM TehRAN SOIlS
each year (9). Likewise, bacterial-based bio-control 
products  have  now  been  commercially  developed 
for control of fungal spoilage of food products and 
agricultural commodities (14). It has been shown that 
production of an extremely wide array of bioactive 
compounds  by  bacteria  and  their  potential  for  use 
in  biocontrol  programs  is  completely  dependent 
on  parameters  such  as  taxonomical  position  and 
physiological  characters  (i.e.  species,  varieties  and 
growth cycle), geographic condition, soil composition, 
etc. So, screening of a large number of bacteria from 
different  geographic  locations  may  increase  the 
chance of finding novel bioactive compounds with 
broad spectrum antifungal activity.   
In  the  present  study,  to  maximize  the  chance 
for  isolating  bacteria  suitable  as  rich  sources  of 
antifungal  bioactive  metabolites  as  well  as  for 
potential development of biological control agents for 
use against fungi, we isolated and screened bacterial 
populations  from  Tehran  soil  samples.  A  number 
of  16  antagonistic  bacteria  with  strong  inhibitory 
activity against selected fungi were isolated from 148 
soil  samples  and  identified  in  the  genera  Bacillus, 
Pseudomonas, Acinetobacter and Streptomyces using 
16S rRNA sequence analysis. Inhibitory bacteria with 
antifungal activity against some selected fungi were 
isolated from approximately 25.0% of soil samples of 
which about 16.5% were reported as strong inhibitors 
of fungal growth in bioassays. They were identified in 
the genera Bacillus (B. subtilis, B. amyloliquefaciens 
and  B.  valismortis),  Acinetobacter ( A.  baumannii), 
Pseudomonas ( P.  chlororaphis)  and  Streptomyces 
(an unidentified species). All these species exhibited 
considerable inhibitory activity toward the growth of 
all tested fungi in variable degrees which indicate that 
population diversity is an extremely important factor 
determining the potential for antagonistic activity of 
bacteria  toward  various  microorganisms.  Our  data 
indicated reliability of GY agar as a suitable low cost 
and easy screening test for evaluating antagonistic 
activities of a large number of bacteria against fungi 
from different genera. 
As  reported  by  other  researchers,  the  genera 
Bacillus, Pseudomonas, Agrobacterium and Streptomy-
ces have been considered as main bacterial genera 
capable of producing antifungal bioactive metabolites 
(15,  16).  In  the  present  study,  the  genus  Bacillus 
was the most important antagonistic bacterial group 
which  comprised  around  80.0%  of  the  inhibitory 
isolates.  Within  Bacillus  species,  B.  subtilis  as 
the  most  important  species  and  in  some  extents 
other  species  such  as  B.  amyloliquefaciens  and  B. 
valismortis are reported to produce a wide range of 
structurally  related  antimicrobial  compounds  and 
they are usually isolated from the soil as the main 
natural  habitat  (17-20). Among  active  compounds, 
with amazing variety of structures produced by B. 
subtilis, peptide antibiotics represent the predominant 
class. The iturin family contains the closely related 
cyclic  lipopeptides  the  iturins,  mycosubtilins  and 
bacillomycins  with  anti-fungal  activities  (15,  17). 
Members of the genus Pseudomonas also comprise a 
large group of the active biocontrol strains as a result 
of their general ability to produce a diverse array of 
potent antifungal metabolites. Antibiotic production 
by  fluorescent  pseudomonads  was  recognized  as 
an  important  feature  in  plant  disease  suppression 
by  some  strains. These include  simple metabolites 
such  as  2,4-diacetylphloroglucinol,  phenazine-1-
carboxylic acid and pyrrolnitrin [3-chloro-4-(2’-nitro-
3’-chlorophenyl)-pyrrole],  as  well  as  the  complex 
macrocyclic  lactone,  2,3-de-epoxy-2,3-didehydra-
rhizoxin.  Pyrrolnitrin  is  active  against  Rhizoctonia 
spp, Fusarium spp, and other phytopathogenic fungi, 
and it has been used as a model in the development of 
a new phenylpyrrole agricultural fungicide (21-23). 
The strong inhibitory activity of Bacillus species as 
well as other bacteria, specially A. baumannii and 
P.  chlororaphis  isolated  in  the  present  study,  may 
be attributed to production of antifungal peptides by 
Bacillus strains (15-20) and production of aerugine, 
phenazine, and phloroglucinol antibiotics by Pseudomo-
nas species (21-23). 
With  respect  to  the  considerable  tolerance  of  B. 
subtilis and P. chlororaphis to environmental stresses 
and their facile production by current fermentation 
technology, bacterial isolates identified in this study 
with a diverse range of antifungal activities may be 
considered as potential sources of novel antifungal 
bioactive metabolites as well as promising candidates 
to  develop  new  biocontrol  agents  for  controlling 
pathogenic  fungi  in  medicine  and  agriculture.  We 
have  demonstrated  that  P.  chlororaphis  S105  may 
produce  antifungal  compounds  suitable  to  control 
the fungal diseases as a promising eco-friendly tool. 
Future  studies  to  identify  antifungal  metabolites 
of antagonistic bacteria isolated here, to determine 
their mechanisms of action on fungal cells and their 
evaluation as effective fungal biocontrol agents in the 
field are recommended.146 RANjBARIyAN  eT Al .                                                                                              IRAN. J. MICROBIOL. 3 (3) : 140-146 
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